Sio Gene Therapies SIOX

Quarterly report 2022-Q4
added 02-14-2023

Country	Britain
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	52.2 M
Market Cap^[1]	$ 30.3 M
EBITDA (LTM)	$ -56.2 M
P/E (LTM)	-
P/S (LTM)	-
EPS (LTM)	-0.6

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.